Evidence map›Paper›PMID 21716958›Full record

ArticleFrontiers in microbiology2011

The Differential Effect of Toxoplasma Gondii Infection on the Stability of BCL2-Family Members Involves Multiple Activities.

John Cherrington Carmen, Anthony Peter Sinai

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
13.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 184 citations in OpenAlex.

  1. Article
  2. Host-Frontiers in immunology · 2017
    Review
  3. Lytic Cycle of Toxoplasma gondii: 15 Years Later.Annual review of microbiology · 2015
    Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

John Cherrington CarmenDepartment of Microbiology, Immunology, and Molecular Genetics, University of Kentucky College of Medicine Lexington, KY, USA.
Anthony Peter Sinai
University of Kentucky · US

Funding

Blockade of host apoptosis by Toxoplasma gondiiR01AI049367 · NIAID · UNIVERSITY OF KENTUCKY · PI SINAI, ANTHONY P. · 2001 to 2010
$2.6M
Training Program in Microbial PathogenesisT32AI049795 · NIAID · UNIVERSITY OF KENTUCKY · PI STRALEY, SUSAN C · 2001 to 2005
$841k
NIAID NIH HHS R01 AI049367NIAID NIH HHS T32 AI049795
6 · The paper itself

Abstract

The regulation of mitochondrial permeability, a key event in the initiation of apoptosis is governed by the opposing actions of the pro- and anti-apoptotic members of the BCL2-family of proteins. The BCL2-family can be classified further based on the number of BCL-homology (BH) domains they encode. Pathogen mediated modulation of BCL2-family members play a significant role in their ability to affect the apoptotic pathways in the infected host cell. The protozoan parasite Toxoplasma gondii establishes a profound blockade of apoptosis noted by a requirement for host NFκB activity and correlating with the selective degradation of pro-apoptotic BCL2-family members. In this study, we explore the potential activities associated with the inherent stability of the anti-apoptotic BCL2 as well as the selective degradation of the pro-apoptotic proteins BAX, BAD, and BID. We find that multiple activities govern the relative stability of BCL2-family members suggesting a complex and balanced network of stability-enhancing and-destabilizing activities are perturbed by parasite infection. The data leave open the possibility for both parasite induced host activities as well as the direct consequence of parasite effectors in governing the relative levels of BCL2-proteins in the course of infection.

Indexed as

apoptosisBCL2NFκBprotease inhibitionproteasomeToxoplasma gondii

Identifiers

PMID21716958
PMCPMC3109420
OpenAlexW2129342724

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.